Key result
Atherogenic Index of Plasma ≥ 0.21 identifies ~55% of T2DM patients at high cardiovascular risk.
Why the study?
Cardiovascular disease is the leading cause of mortality and morbidity in T2DM patients, motivating analysis of cardiovascular complication risk based on the Atherogenic Index of Plasma and its influencing factors.
Population
85 T2DM patients from primary health care in Medan, Indonesia
Design
Cross-sectional study
Authors
Loading...
AIP may support CV risk assessment in T2DM; hypothesis-generating and requires prospective validation before clinical adoption.
Cross-Sectional (n=85)
No
In T2DM patients, the Atherogenic Index of Plasma is significantly associated with fasting blood glucose, HbA1c, and lipid parameters, highlighting its potential utility in assessing cardiovascular risk.
Amelia et al. (2020) conducted a cross-sectional in Type 2 Diabetes Mellitus (n=85). Atherogenic Index of Plasma (AIP) vs. Low or intermediate AIP (<0.21) was evaluated on High risk of cardiovascular complication (AIP ≥ 0.21). An Atherogenic Index of Plasma ≥ 0.21 identified 55.3% of patients with type 2 diabetes mellitus as being at high risk for cardiovascular complications.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: